These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 37964395)

  • 1. Comparison of post-COVID-19 vaccination hypermetabolic lymphadenopathy on
    Chiang MT; Wang JT; Lin WY; Yen RF; Huang JY; Lu CC
    Eur J Med Res; 2023 Nov; 28(1):513. PubMed ID: 37964395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypermetabolic lymphadenopathy following administration of BNT162b2 mRNA Covid-19 vaccine: incidence assessed by [
    Cohen D; Krauthammer SH; Wolf I; Even-Sapir E
    Eur J Nucl Med Mol Imaging; 2021 Jun; 48(6):1854-1863. PubMed ID: 33774684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FDG PET/CT radiomics as a tool to differentiate between reactive axillary lymphadenopathy following COVID-19 vaccination and metastatic breast cancer axillary lymphadenopathy: a pilot study.
    Eifer M; Pinian H; Klang E; Alhoubani Y; Kanana N; Tau N; Davidson T; Konen E; Catalano OA; Eshet Y; Domachevsky L
    Eur Radiol; 2022 Sep; 32(9):5921-5929. PubMed ID: 35385985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [
    Skawran S; Gennari AG; Dittli M; Treyer V; Muehlematter UJ; Maurer A; Burger IA; Mader C; Messerli O; Grünig H; Gebhard C; Huellner MW; Curioni-Fontecedro A; Berger C; Messerli M
    Eur Radiol; 2022 Jan; 32(1):508-516. PubMed ID: 34156552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency and Characteristics of Nodal and Deltoid FDG and
    Schroeder DG; Jang S; Johnson DR; Takahashi H; Navin PJ; Broski SM; Thorpe MP; Johnson GB; Young JR
    AJR Am J Roentgenol; 2021 Nov; 217(5):1206-1216. PubMed ID: 34009000
    [No Abstract]   [Full Text] [Related]  

  • 6. Absolute Lymphocyte Count After COVID-19 Vaccination Is Associated with Vaccine-Induced Hypermetabolic Lymph Nodes on
    Seban RD; Richard C; Nascimento-Leite C; Ghidaglia J; Provost C; Gonin J; Tourneau CL; Romano E; Deleval N; Champion L
    J Nucl Med; 2022 Aug; 63(8):1231-1238. PubMed ID: 34857663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A sigh of relief: vaccine-associated hypermetabolic lymphadenopathy following the third COVID-19 vaccine dose is short in duration and uncommonly interferes with the interpretation of [
    Cohen D; Hazut Krauthammer S; Wolf I; Even-Sapir E
    Eur J Nucl Med Mol Imaging; 2022 Mar; 49(4):1338-1344. PubMed ID: 34651230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 Vaccination-Related Uptake on FDG PET/CT: An Emerging Dilemma and Suggestions for Management.
    McIntosh LJ; Bankier AA; Vijayaraghavan GR; Licho R; Rosen MP
    AJR Am J Roentgenol; 2021 Oct; 217(4):975-983. PubMed ID: 33646823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccine-Related Lymph Nodes: The Emerging Pitfalls of 18F-Fluorocholine and 68Ga-PSMA-11 PET/CT in the Era of COVID-19 Vaccination.
    Ah-Thiane L; Ferrer L; Maucherat B; Fleury V; Le Thiec M; Rusu D; Rousseau C
    Clin Nucl Med; 2022 Jul; 47(7):575-582. PubMed ID: 35675134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 Vaccination-Associated Lymphadenopathy on FDG PET/CT: Distinctive Features in Adenovirus-Vectored Vaccine.
    Shin M; Hyun CY; Choi YH; Choi JY; Lee KH; Cho YS
    Clin Nucl Med; 2021 Oct; 46(10):814-819. PubMed ID: 34115709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypermetabolic abdominal and cervical lymph nodes mimicking Hodgkin lymphoma relapse on FDG PET/CT after adenovirus-vectored COVID-19 vaccine.
    Landete E; Gómez-Fernández I; González-Gascón-Y-Marín I; Durán-Barquero C; Churruca J; Infante MS; Muñoz-Novas C; Foncillas MÁ; Marín K; Ramos-de-Ascanio V; Alonso-Farto JC; Hernández-Rivas JÁ
    Hum Vaccin Immunother; 2021 Dec; 17(12):5129-5132. PubMed ID: 34920695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Axillary lymph node characteristics in breast cancer patients versus post-COVID-19 vaccination: Overview of current evidence per imaging modality.
    van Nijnatten TJA; Jochelson MS; Lobbes MBI
    Eur J Radiol; 2022 Jul; 152():110334. PubMed ID: 35512513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphadenopathy post-COVID-19 vaccination with increased FDG uptake may be falsely attributed to oncological disorders: A systematic review.
    Bshesh K; Khan W; Vattoth AL; Janjua E; Nauman A; Almasri M; Mohamed Ali A; Ramadorai V; Mushannen B; AlSubaie M; Mohammed I; Hammoud M; Paul P; Alkaabi H; Haji A; Laws S; Zakaria D
    J Med Virol; 2022 May; 94(5):1833-1845. PubMed ID: 35060149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenging Axillary Lymph Nodes on PET/CT in Cancer Patients throughout COVID-19 Vaccination Era.
    Giordano A; Gallicchio R; Milella M; Storto R; Nardelli A; Pellegrino T; Nappi A; Di Cosola M; Storto G
    Curr Pharm Des; 2024; 30(10):798-806. PubMed ID: 38454762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The incidence and duration of COVID-19 vaccine-related reactive lymphadenopathy on
    El-Sayed MS; Wechie GN; Low CS; Adesanya O; Rao N; Leung VJ
    Clin Med (Lond); 2021 Nov; 21(6):e633-e638. PubMed ID: 34862224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization of FDG PET study after mRNA COVID-19 vaccination to reduce the interference of vaccine-associated hypermetabolic lymphadenopathy.
    Thaweerat W
    Ann Nucl Med; 2022 Mar; 36(3):327-328. PubMed ID: 35094260
    [No Abstract]   [Full Text] [Related]  

  • 17. The systemic impact of different COVID-19 vaccines in 2-[18F] FDG-PET/CT.
    Nazerani-Zemann T; Pernthaler B; Schwantzer G; Gstettner C
    Sci Rep; 2023 Dec; 13(1):21838. PubMed ID: 38071353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 mRNA Vaccination: Age and Immune Status and Its Association with Axillary Lymph Node PET/CT Uptake.
    Eifer M; Tau N; Alhoubani Y; Kanana N; Domachevsky L; Shams J; Keret N; Gorfine M; Eshet Y
    J Nucl Med; 2022 Jan; 63(1):134-139. PubMed ID: 33893188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. US Evaluation of Axillary Lymphadenopathy Following COVID-19 Vaccination: A Prospective Longitudinal Study.
    Ha SM; Chu AJ; Lee J; Kim SY; Lee SH; Yoen H; Cho N; Moon WK; Chang JM
    Radiology; 2022 Oct; 305(1):46-53. PubMed ID: 35471107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolving Bilateral Hypermetabolic Axillary Lymphadenopathy on FDG PET/CT Following 2-Dose COVID-19 Vaccination.
    Weeks JK; O'Brien SR; Rosenspire KC; Dubroff JG; Pantel AR
    Clin Nucl Med; 2021 Dec; 46(12):1011-1012. PubMed ID: 34735411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.